Table 2. Preliminary Analysis after 24 Weeks with ABT-378/d4T/3TC (N=101)

Intent-to-Treat As-Treated

HIV RNA <400 copies/ml 86.1% 94.5%
HIV RNA <50 copies/ml* 75.0% 88.8%

*Performed on a subgroup of 32 patients only.